• March 1, 2021

Cannabis tax dollars being spent on private research, not on efficacy

 Cannabis tax dollars being spent on private research, not on efficacy

It appears Colorado State University-Pueblo didn’t get the message. The university’s Institute for Cannabis Research is still spending tax dollars on research for a private company, not on studying the efficacy of cannabis.

This from the Grand Junction Daily Sentinel’s Charles Ashby:

Despite a clear rejection by the Colorado Legislature, the state’s only cannabis research center is going ahead with developing a seed-to-sale marijuana-tracking system that no one in the industry says they want.

There has been evidence to suggest the research and development would benefit single company, a British company known as PhytoTrack. If in fact CSU Pueblo is spending tax dollars on private research and development, that alone would be cause for alarm.

The health and safety aspect is the kicker. We have no idea what the impacts are of spraying cannabis with a substance for tracking purposes.

This entire project rings of a bad idea.

Read the story in The Sentinel

Peter Marcus

Peter Marcus served as the Senior Statehouse Reporter for the Colorado Springs Gazette where he co-launched ColoradoPolitics.com, covering politics, the governor’s office, the Colorado Legislature, Congress, and federal, state and local governments. He joined in November 2016 from The Durango Herald. The Washington Post twice named Marcus one of the top state-based political and legislative reporters in the nation. He also has won over a dozen awards from the Colorado Press Association. In prior positions, Marcus worked for the Colorado Statesman, a Denver-based political weekly, and The Denver Daily News, a former free daily newspaper in Denver, where he covered City Hall, politics, and had an entertainment column. Before that, Marcus worked for the Longmont Times-Call. An Ithaca College graduate, Marcus studied journalism and creative writing, before moving to Colorado from New York in 2004.

Subscribe To Our Newsletter


Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!